Feasibility and safety of PIPAC combined with additional surgical procedures: PLUS study
- 7 May 2022
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 48 (10) , 2212-2217
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Single-port access for Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC): technique, feasibility and safetyPleura and Peritoneum, 2016
- Short-term outcome in patients treated with cytoreduction and HIPEC compared to conventional colon cancer surgeryMedicine, 2016
- Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosisWorld Journal of Surgical Oncology, 2016
- Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasisColorectal Disease, 2016
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal MetastasisJournal of Gastrointestinal Surgery, 2015
- Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: A phase 2 studyGynecologic Oncology, 2015
- Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for EfficacyAnnals of Surgical Oncology, 2013
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Occupational Health and Safety AspectsAnnals of Surgical Oncology, 2013
- Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei—a report of 103 proceduresEuropean Journal of Surgical Oncology, 2006
- Toxicity of cytoreductive surgery and hyperthermic intra‐peritoneal chemotherapyJournal of Surgical Oncology, 2004